It primarily works by inhibiting NF-κB and GSK-3β signaling pathways (117), reducing pro-inflammatory cytokine release, and regulating the differentiation of Treg/Th17 cells in the treatment of sepsis. This evidence concerns the gene NFKB1 and Sepsis.